Article metrics

Download PDFPDF

578 Feasibility of eftilagimod alpha (soluble LAG-3 protein) combined with standard-of-care-therapy in advanced non-small-cell lung cancer (NSCLC) adenocarcinomas. Initial results from INSIGHT–003
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to January 2024

AbstractFullPdf
Nov 2022301030
Dec 202259014
Jan 20231603
Feb 202311007
Mar 20234805
Apr 20233802
May 20237109
Jun 20238501
Jul 20234903
Aug 20231802
Sep 20231700
Oct 20237805
Nov 20233003
Dec 20234204
Jan 20241803
Total980091